![](https://investorshub.advfn.com/uicon/213674.png?cb=1480417277)
Monday, September 06, 2010 8:00:02 PM
so many need this and short supply,
Products Affected - Description
Thiamine hydrochloride (vitamin B1) for injection 100 mg/mL, 1 mL vials (NDC 63323-0013-02), APP
Reason for the Shortage
APP could not provide a reason for the shortage. APP is the sole supplier of thiamine injection.
Oral preparations of thiamine are not affected by this shortage.
Estimated Resupply Dates
APP has thiamine injection on back order and the company estimates a release date of late-August, 2010.
Tobramycin Solution for Injection, APP
40 mg/mL, 50 mL vial (NDC 63323-0306-51)
40 mg/mL, 2 mL Novaplus vial (NDC 63323-0306-55)
Estimated Resupply Dates
APP has available tobramycin 40 mg/mL solution for injection in 2 mL (NDC 63323-0306-02), 30 mL (NDC 63323-0306-30), and 30 mL Novaplus (NDC 63323-0306-56) vials. Tobramycin 50 mL vials and 2 mL Novaplus vials are on back order with an estimated release date of late-August, 2010
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM